BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38347540)

  • 1. IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation.
    Yang J; Chen J; Chang J; Sun X; Wei Q; Cai X; Cao P
    Cell Commun Signal; 2024 Feb; 22(1):116. PubMed ID: 38347540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M and STAT3 Signaling Pathways Support Human Trophoblast Differentiation by Inhibiting Inflammatory Stress in Response to IFNγ and GM-CSF.
    Ravelojaona M; Girouard J; Kana Tsapi ES; Chambers M; Vaillancourt C; Van Themsche C; Thornton CA; Reyes-Moreno C
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells.
    Chen J; Yang J; Wei Q; Weng L; Wu F; Shi Y; Cheng X; Cai X; Hu C; Cao P
    Cell Commun Signal; 2020 Apr; 18(1):55. PubMed ID: 32245484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
    Huang R; Liao X; Li J; Wei J; Su X; Lai X; Liu B; Zhu F; Huang Y; Li Q
    Oncol Rep; 2019 May; 41(5):2876-2888. PubMed ID: 30896832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation.
    Wang Y; Cai D; Brendel C; Barett C; Erben P; Manley PW; Hochhaus A; Neubauer A; Burchert A
    Blood; 2007 Mar; 109(5):2147-55. PubMed ID: 17090651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant
    Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
    Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell leukemia virus type 2 induces survival and proliferation of CD34(+) TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor.
    Bovolenta C; Pilotti E; Mauri M; Turci M; Ciancianaini P; Fisicaro P; Bertazzoni U; Poli G; Casoli C
    Blood; 2002 Jan; 99(1):224-31. PubMed ID: 11756175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
    Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
    Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours.
    Zhang X; Blaskovich MA; Forinash KD; Sebti SM
    Br J Cancer; 2014 Aug; 111(5):894-902. PubMed ID: 24983364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
    Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
    J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy.
    Zeng P; Lu W; Tian J; Qiao S; Li J; Glorieux C; Wen S; Zhang H; Li Y; Huang P
    J Hematol Oncol; 2022 Mar; 15(1):30. PubMed ID: 35313945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants.
    Gao M; Zhu H; Fu L; Li Y; Bao X; Fu H; Quan H; Wang L; Lou L
    Cancer Sci; 2019 Oct; 110(10):3306-3314. PubMed ID: 31361380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.
    Cozzolino F; Torcia M; Bettoni S; Aldinucci D; Burgio VL; Petti MC; Rubartelli A; Barbui T; Rambaldi A
    Int J Cancer; 1990 Nov; 46(5):902-7. PubMed ID: 1699903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.
    Ogawara Y; Katsumoto T; Aikawa Y; Shima Y; Kagiyama Y; Soga T; Matsunaga H; Seki T; Araki K; Kitabayashi I
    Cancer Res; 2015 May; 75(10):2005-16. PubMed ID: 25795706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony stimulating factor gene.
    Hoyle PE; Steelman LS; McCubrey JA
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):159-68. PubMed ID: 9426974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
    Drexler HG; Zaborski M; Quentmeier H
    Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor regulates the activation of inflammatory signals in macrophages and trophoblast cells.
    Hamelin-Morrissette J; Dallagi A; Girouard J; Ravelojaona M; Oufqir Y; Vaillancourt C; Van Themsche C; Carrier C; Reyes-Moreno C
    Mol Immunol; 2020 Apr; 120():32-42. PubMed ID: 32045772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
    Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
    Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.